Patent · US Active

Polymorphic forms

US8288401B2 · kind B2 · utility

5Cited by

1References

16Claims

0Family size

Assignee

Generics [UK] Limited · GB

Inventors

Abhay Gaitonde · Jamkhed, IN
Bindu Manojkumar · Jamkhed, IN
Sandeep Mekde · Jamkhed, IN
Dattaatraya Shinde · Jamkhed, IN
Prakash Bansode · Hyderabad, IN

Key dates

Filing date	May 8, 2008
Grant date	Oct 16, 2012
Priority date	—
Expiry date	May 8, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel polymorphic forms of bosentan and processes for their preparation are disclosed. Further, pharmaceutical compositions comprising said polymorphic forms and the use of said compositions in the treatment of patients suffering from endothelin receptor mediated disorders, for example, cardiovascular disorders such as hypertension, pulmonary hypertension, ischemia, vasospasm and angina pectoris are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.